NeuroEthics and the BRAIN Initiative: Where Are We? Where Are We Going?

Consciousness brain brain computer interfaces brain fingerprinting deep brain stimulation neural networks

Journal

AJOB neuroscience
ISSN: 2150-7759
Titre abrégé: AJOB Neurosci
Pays: United States
ID NLM: 101518076

Informations de publication

Date de publication:
Historique:
entrez: 28 7 2020
pubmed: 28 7 2020
medline: 28 4 2021
Statut: ppublish

Résumé

From its inception, the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, an ambitious project focused on understanding the human brain, has made a concerted effort to integrate neuroethics into its science. In the past five years, the BRAIN Initiative has given rise to powerful tools and neurotechnologies capable of probing deeply into the brain circuits in animal models. As these tools mature and move to human applications they will raise a host of important neuroethical considerations not just for the medical community but for society as a whole. Now marks a pivotal moment to assess the status and consider the future of the BRAIN Initiative's neuroethics efforts. Here we describe core issues of neuroscience advances, the state of neurotechnologies in human neuroscience, and how ethics will be incorporated into the BRAIN Initiative as this ten-year project enters its second phase. BRAIN Initiative neurotechnologies have immense potential to transform the way we diagnose and treat neurological disease; therefore, they may become more commonplace in research, medicine, and society. We also discuss future global efforts to ensure continued guidance and open dialogue surrounding neuroethics.

Identifiants

pubmed: 32716747
doi: 10.1080/21507740.2020.1778119
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Commentaires et corrections

Type : CommentIn

Auteurs

Walter J Koroshetz (WJ)

National Institute of Neurolgogical Disorders and Stroke.

Jackie Ward (J)

National Institute of Neurolgogical Disorders and Stroke.

Christine Grady (C)

National Institutes of Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH